| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +2,100 | 0.33% | $25.30 | +$53,140 |
| Sells | 8 | -625,786 | 100% | $36.72 | -$22,980,710 |
| Net | -7 | -623,686 | -99% | -$22,927,570 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James P. Mackin | President & CEO | $36,413,942 | -$9,038,581 | -20% | 03 Dec 2025 |
| David Ashley Lee | Executive VP, COO & CFO | $6,655,986 | 01 Mar 2023 | ||
| Amy Horton | VP, Chief Accounting Officer | $5,777,046 | -$1,141,309 | -16% | 08 Dec 2025 |
| John E. Davis | Chief Commercial Officer | $4,731,988 | -$2,320,966 | -33% | 31 Dec 2025 |
| Jean F Holloway | SVP, General Counsel | $4,102,359 | -$4,391,595 | -52% | 31 Dec 2025 |
| Lance A. Berry | Executive VP, CFO | $3,805,733 | -$210,754 | -5.2% | 06 Mar 2025 |
| Daniel J. Bevevino | Director | $3,577,454 | 22 May 2025 | ||
| Thomas F. Ackerman | Director | $3,573,520 | 22 May 2025 | ||
| Jon W. Salveson | Director | $3,095,385 | 22 May 2025 | ||
| Ronald D McCall | Director | $2,191,824 | 25 Aug 2021 | ||
| Harvey Morgan | Director | $1,747,980 | 30 Aug 2021 | ||
| James Bullock | Director | $1,636,544 | 22 May 2025 | ||
| Jeffrey H. Burbank | Director | $1,282,496 | 22 May 2025 | ||
| Elizabeth A. Hoff | Director | $1,226,169 | -$189,412 | -13% | 18 Nov 2025 |
| Marshall Stanton | SVP, Clinical & MD Affair | $1,191,971 | -$5,614,066 | -82% | 31 Dec 2025 |
| Marna Borgstrom | Director | $1,170,257 | 22 May 2025 | ||
| Anthony B. Semedo | Director | $1,121,341 | -$20,887 | -1.8% | 23 May 2025 |
| Andrew M. Green | VP Regulatory | $1,005,090 | 04 Dec 2024 | ||
| Rochelle Maney | VP, Quality | $871,883 | 01 Mar 2024 | ||
| Matthew A. Getz | VP, Human Resources | $863,527 | 16 Aug 2024 | ||
| Dennis Maier | SVP, Operations | $625,032 | 06 Jun 2023 | ||
| Florian Tyrs | VP, Global Operations | $586,120 | 27 Feb 2024 | ||
| Franz Peter Barthold | VP, Research & Development | $585,288 | 08 Nov 2022 | ||
| Robert Thomson | VP Research & Development | $250,735 | 23 Feb 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|